Home limb
 

Keywords :   


Tag: limb

US ONR contracts Battelle and Halyard Health to produce new product for limb injuries

2016-06-13 01:00:00| Naval Technology

Battelle and Halyard Health have been contracted by the US Office of Naval Research (ONR) to co-develop a medical device that can help reduce the loss of tissue in severely injured limbs.

Tags: product health produce contracts

 

Freezing technique may ease 'phantom limb' pain for amputees

2016-04-13 19:26:13| Biotech - Topix.net

A freezing technique may reduce the debilitating phantom limb pain that many amputees experience, according to a new, small study. Chronic pain that emanates from the site of a severed limb can be reduced in some cases when the remaining nerve and scar tissue is frozen in place, researchers said.

Tags: technique pain ease phantom

 
 

Fossil trove adds a new limb to human family tree

2015-09-10 12:00:00| LifeSciencesWorld

[NEWS] MADISON, Wis. — Working in a cave complex deep beneath South Africa's Malmani dolomites, an international team of scientists has brought to light an unprecedented trove of hominin fossils — more than 1,500 well-preserved bones and teeth — representing the largest, most complete set of such remains found to date in Africa. The discovery of the fossils, cached in a barely accessible chamber in a subterranean labyrinth not far from Johannesburg, adds a new bran…

Tags: family human tree adds

 

Two New Post-Hoc Analyses of TRA 2°P TIMI 50 Study Showed ZONTIVITY (vorapaxar) Added to Aspirin and/or Clopidogrel Reduced Acute Limb Ischemia and Peripheral Revascularizations, Respectively, in Certain Patients with Peripheral Arterial Disease

2015-03-05 14:00:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. These and other post-hoc subgroup analyses from TRA-2°P are being presented at the 2015 American College of Cardiology Scientific Sessions KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of ZONTIVITY (vorapaxar), one of the largest secondary prevention studies of an antiplatelet medicine. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orMichael Close, 267-305-1211orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: with added study reduced

 

Farmers go out on limb to grow organic hops

2014-09-11 11:08:15| Beverages - Topix.net

The aroma - a mix of freshly cut grass, pine needles and, strangely enough, watermelon - is sharp and pungent, immediately recognizable to any beer connoisseur. A three-story 1964 picking machine roars like a jet engine as bits of bright green dance from one conveyor belt to another.

Tags: grow organic farmers limb

 

Sites : [1] [2] next »